Skip to content

Ocular and cerebral characteristics in patients with alzheimer's disease: a study of retinal and brain multimodal imaging

Ocular and cerebral characteristics in patients with alzheimer's disease: a study of retinal and brain multimodal imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084575
Enrollment
Unknown
Registered
2024-05-21
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Alzheimers disease patients with retinal changes:None
Alzheimers disease patients without retinal changes:None

Sponsors

The First Affiliated Hospital of the Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 50 and 80 years. (2) All AD patients meet the Chinese Alzheimer's Disease Diagnosis and Treatment Guidelines (2020 edition). (3) Patients who can cooperate to complete the collection of medical history, cognitive assessment, fundus examination, and multimodal imaging examination of the brain.

Exclusion criteria

Exclusion criteria: (1) Patients with a history of ocular diseases such as high myopia, macular degeneration, glaucoma, cataracts, pseudopapilledema syndrome, optic nerve disorders, corneal scars, severe corneal opacities, etc. (2) Cognitive impairment caused by other reasons, such as frontotemporal dementia, Lewy body dementia, dementia due to traumatic brain injury, intracranial infections, intoxication, intracranial space-occupying lesions, endocrine system disorders, or any other cause of cognitive impairment. (3) Known neurologic or systemic chronic diseases that interfere with the neurovascular structure and function of the retina, such as multiple sclerosis, Parkinson's disease, diabetes, rheumatoid arthritis, sarcoidosis, Crohn's disease and ulcerative colitis, severe liver or kidney diseases, cardiovascular or metabolic disorders, etc. (4) Contraindications to magnetic resonance imaging (MRI), such as having a cardiac pacemaker, claustrophobia, etc. (5) Patients with severe cognitive impairment or irreparable visual or hearing impairments who are unable to cooperate with fundus or MRI examinations.

Design outcomes

Primary

MeasureTime frame
Cerebral MRI;Optical Coherence Tomography;Optical Coherence Tomography Angiography;visual electrophysiology;Ocular fundus ;

Secondary

MeasureTime frame
Cognitive questionnaire assessment;Clinical classification of Alzheimer's disease;

Countries

China

Contacts

Public ContactZhao Runze

The First Affiliated Hospital of the Air Force Military Medical University

313173187@qq.com+86 187 1032 1300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026